For example, the whole pancreatic cancer cell vaccine expressing human macrophage-colony stimulating factor (GM-CSF), known as GVAX, combined with a Listeriabased vaccine expressing the PDAC antigen mesothelian (CRS-207) shows promise in extending survival evidenced by both pre-clinical and preliminary clinical data [6]. The gene discussed is CSF2; the disease is pancreatic neoplasm.